+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Pruritus Drugs Market 2024-2028 - Product Thumbnail Image

Pruritus Drugs Market 2024-2028

  • Report
  • October 2024
  • 157 Pages
  • Global
From
Topical Drugs Market 2024-2028 - Product Thumbnail Image

Topical Drugs Market 2024-2028

  • Report
  • August 2024
  • 145 Pages
  • Global
From
From
From
Erythrodermic Psoriasis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Erythrodermic Psoriasis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 52 Pages
  • Global
From
Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Actinic (Solar) Keratosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • March 2025
  • 289 Pages
  • Global
From
Seborrheic Keratosis - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Seborrheic Keratosis - Global Clinical Trials Review, 2025

  • Clinical Trials
  • January 2025
  • 47 Pages
  • Global
From
Hidradenitis Suppurativa - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hidradenitis Suppurativa - Global Clinical Trials Review, 2024

  • Clinical Trials
  • October 2024
  • 183 Pages
  • Global
From
Epidermolysis Bullosa: Competitive Landscape - Product Thumbnail Image

Epidermolysis Bullosa: Competitive Landscape

  • Report
  • October 2024
  • 69 Pages
  • Global
From
From
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 1218 Pages
  • Global
From
Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Generalized Pustular Psoriasis (GPP) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • August 2024
  • 70 Pages
  • Global
From
Topical Skin Infection Treatment Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Topical Skin Infection Treatment Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Systemic Scleroderma Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Systemic Scleroderma Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Skin Burns Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Skin Burns Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Warts Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Warts Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Vitiligo Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Vitiligo Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Scars Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Scars Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Pruritus Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Pruritus Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Eczema Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Eczema Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more